Impact of AIM2 on HNSCC Development

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer often linked to chronic inflammation and immune suppression.
• The precise mechanisms underlying HNSCC development and immune evasion are not fully understood.
• Absent in Melanoma 2 (AIM2) is a cytosolic sensor with known roles in inflammasome activation and tumor suppression.

Purpose of the Study:

• To investigate the role of AIM2 in the development and progression of HNSCC.
• To elucidate the molecular mechanisms by which AIM2 influences the tumor microenvironment and immune response in HNSCC.

Main Methods:

• Utilized a 4-nitroquinoline-N-oxide (4NQO)-induced HNSCC mouse model in wild-type (WT) and Aim2-deficient (Aim2-/-) mice.
• Analyzed tumor size, tissue dysplasia, gene expression (including cytokines and immune markers), and immune cell infiltration via RNA-sequencing and immunohistochemistry.
• Employed Aim2/Rag1-double deficient mice to assess the necessity of the adaptive immune compartment.

Main Results:

• Aim2-/- mice exhibited larger HNSCC tumors and increased dysplasia compared to WT mice.
• AIM2 deficiency led to elevated expression of Interferon-gamma (IFNγ) and Irf1, suggesting AIM2 restricts IFNγ production.
• RNA-sequencing revealed enhanced expression of MHC-related genes, cell killing, and T cell activation markers in Aim2-/- mice, alongside increased macrophage infiltration.
• Tumorigenesis was exacerbated in AIM2-deficient mice, and this effect was dependent on the adaptive immune compartment.

Conclusions:

• AIM2 plays a critical role in restricting oral tumor development in HNSCC.
• AIM2 appears to limit HNSCC progression by regulating IFNγ production and adaptive immune responses.
• These findings highlight AIM2 as a potential therapeutic target for HNSCC.